TITLE

A case of march fracture in a patient with osteoporosis on long-term HAART

AUTHOR(S)
Forsyth, Sophie F.; Gazzard, Brian G.; Nelson, Mark R.
PUB. DATE
September 2002
SOURCE
International Journal of STD & AIDS;Sep2002, Vol. 13 Issue 9, p645
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the consideration of osteoporosis as a diagnosis in patients with HIV infection. A 50-year-old man, who was given a highly active antiretroviral therapy, was gathered with data on the nature and effects of the treatment. Results indicate that HIV-infected patients are prone to risks of accelerated bone demineralization, however, HIV's association with osteoporosis is uncertain.
ACCESSION #
22203559

 

Related Articles

  • Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers. McComsey, Grace A.; Tebas, Pablo; Shane, Elizabeth; Yin, Michael T.; Overton, E. Turner; Huang, Jeannie S.; Aldrovandi, Grace M.; Cardoso, Sandra W.; Santana, Jorge L.; Brown, Todd T. // Clinical Infectious Diseases;10/15/2010, Vol. 51 Issue 8, p937 

    Low bone mineral density (BMD) is prevalent in human immunodeficiency virus (HIV)-infected subjects. Initiation of antiretroviral therapy is associated with a 2%-6% decrease in BMD over the first 2 years, a decrease that is similar in magnitude to that sustained during the first 2 years of...

  • High prevalence of radiological vertebral fractures in HIV-infected males. Torti, Carlo; Mazziotti, Gherardo; Soldini, Pier; FocĂ , Emanuele; Maroldi, Roberto; Gotti, Daria; Carosi, Giampiero; Giustina, Andrea // Endocrine (1355008X);Jun2012, Vol. 41 Issue 3, p512 

    Age-related co-morbidities including osteoporosis are relevant in patients responding to combination antiretroviral therapy (cART). Vertebral fractures are common osteoporotic fractures and their diagnosis is useful for managing at-risk individuals. However, there are few data from HIV-infected...

  • HIV and Bone Disease: A Perspective of the Role of microRNAs in Bone Biology upon HIV Infection. Del Carpio-Cano, Fabiola E.; DeLa Cadena, Raul A.; Sawaya, Bassel E. // Journal of Osteoporosis;2013, p1 

    Increased life expectancy and the need for long-termantiretroviral therapy have brought newchallenges to the clinical management of HIV-infected individuals. The prevalence of osteoporosis and fractures is increased in HIV-infected patients; thus optimal strategies for risk management and...

  • Evaluation of Bone Mineral Density in Iranian HIV/AIDS Patients. Badie, Banafsheh Moradmand; Soori, Tahereh; Kheirandish, Parastoo; Izadyar, Saeed; SeyedAlinaghi, SeyedAhmad; Foroughi, Maryam; Rostamian, Alireza; Mohraz, Minoo // Acta Medica Iranica;2011, Vol. 49 Issue 7, p460 

    Bone disorders have emerged as a worrisome complication in HIV-infected patients in recent years. It is not clear that HIV infection itself or antiretroviral treatment or both are causes of bone loss. However, most studies have found a high prevalence of osteopenia and osteoporosis in HIV/AIDS...

  • Osteoporosis and fracture risk higher with HIV plus HCV than without.  // HIV Treatment ALERTS!;Nov2014, p46 

    The article reports on a combined analysis which indicates that people with HIV infection have higher osteoporosis and fracture risk than people without HIV. The researchers examined the traditional risk factors from HIV infection and hepatitis C virus (HCV). It implies that HIV-positive people...

  • Bone disease in HIV infection. Saccomanno, Maristella Francesca; Ammassari, Adriana // Clinical Cases in Mineral & Bone Metabolism;2011, Vol. 8 Issue 1, p33 

    The advent of highly active anti-retroviral therapy (HAART) has dramatically decreased the rate of AIDS-related mortality and significantly extended the life span of patients with AIDS. A variety of metabolic side effects are associated with these therapies, one of which is metabolic bone...

  • Bone Loss May Be Linked to HIV, Not Therapy.  // Bay Area Reporter;2/26/2004, Vol. 34 Issue 9, OUTReach p1 

    Discusses a research linking bone loss with HIV infection, not antiretroviral therapy. Bone mineral density levels of HIV positive subjects; Risk of HIV positive patients for osteopenia and osteoporosis.

  • Delayed Progression to Death and to AIDS in a Hong Kong Cohort of Patients with Advanced HIV Type 1 Disease During the Era of Highly Active Antiretroviral Therapy. Ka Hing Wong; Kenny Chi Wai Chan; Shui Shan Lee // Clinical Infectious Diseases;9/15/2004, Vol. 39 Issue 6, p853 

    Background. The magnitude of the impact of highly active antiretroviral therapy (HAART) since its introduction in non-Western countries is not entirely clear. We studied disease progression among adult patients with advanced human immunodeficiency virus type 1 (HIV-1) infection in the pre-HAART...

  • Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study. Panos, George; Samonis, George; Alexiou, Vangelis G.; Kavarnou, Garyfallia A.; Charatsis, Gerasimos; Falagas, Matthew E. // Current HIV Research;May2008, Vol. 6 Issue 3, p257 

    HAART has substantially decreased mortality and morbidity among HIV-infected patients. We retrospectively analyzed morbidity and mortality in a cohort of HIV-infected adult patients with prolonged and frequent follow up (1987-2006). The study was divided in pre-HAART and HAART period for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics